| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Cardiotoxicity Brana I; Tabernero JAnn Oncol  2010[Oct]; 21 Suppl 7 (ä): vii173-9Cancer treatment has improved extraordinarily in recent years. The development of  targeted therapies has widened the cardiotoxic spectrum of antineoplastic drugs.  Optimum management of cardiovascular disease before and during antineoplastic  treatment is essential to reduce morbidity and mortality in cancer patients. This  article reviews the incidence and characteristics of cardiotoxic effects of  antineoplastic drugs with special focus on the pathophysiological mechanisms. It  also emphasizes the importance of early detection and correction of  cardiovascular risk factors and the relevance of close cardiac monitoring during  antineoplastic treatment in order to reduce cardiotoxicity.|Antineoplastic Agents/*adverse effects[MESH]|Arrhythmias, Cardiac/chemically induced/drug therapy/physiopathology/prevention &  control[MESH]|Cardiovascular Agents/therapeutic use[MESH]|Heart Diseases/*chemically induced/epidemiology/prevention & control[MESH]|Humans[MESH]|Incidence[MESH]|Ischemia/chemically induced/complications/drug therapy/prevention & control[MESH]|Molecular Targeted Therapy/methods[MESH]|Neoplasms/drug therapy/epidemiology[MESH]|Ventricular Dysfunction, Left/chemically induced/drug therapy/prevention &  control[MESH]
 |